Law360, New York (February 08, 2011, 1:59 PM ET) -- The plaintiffs’ counsel in a shareholder class action against Pfizer Inc. executives over an allegedly fraudulent marketing campaign have asked a judge to sanction $22 million in attorneys’ fees as part of the final approval of a $75 million settlement.
The hefty fee award is warranted by both the significant cash value of the settlement and governance changes the settlement agreement will enact at the company, the attorneys said in a motion for final approval of the settlement, filed Monday in the U.S. District Court for...
Attorneys Seek $22M In Fees For Pfizer Settlement
To view the full article, take a free trial now.
